JF Toussaint obtained his PhD in bioengineering and animal sciences from the University of Gembloux in Belgium. He then joined the Belgian reference diagnostic laboratory for animal diseases. He joined GSK in 2006 to lead the development of clinical laboratory assays for the dengue vaccine program. He then led cross-functional vaccine development teams for dengue disease and respiratory syncytial virus. In 2015, he became Head of the Discovery Unit in GSK Vaccine’s Belgian R&D center, where he overseas several discovery programs, translational sciences activities as well as GSK’s adjuvant center of excellence.
JF puts a strong emphasis on the value of scientific collaborations with academics, public and private research centers and other pharma companies. He has actively contributed to several sizable deals at GSK. JF obtained an MBA from HEC Paris.
MEET JEAN-FRANCOIS TOUSSAINT AT #KFG2018
JF Toussaint will give a presentation in the session "Partnering Opportunities":
"Opening a new vaccine era through innovation"